Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density

American Journal of Human Genetics

Volumn 72, Issue 3, 2003, Pages 763-771

  Van Wesenbeeck, Liesbeth ^a   Cleiren, Erna ^a   Gram, Jeppe ^b   Beals, Rodney K ^c   Bénichou, Olivier ^d   Scopelliti, Domenico ^e   Key, Lyndon ^f   Renton, Tara ⁱ   Bartels, Cindy ^g   Gong, Yaoqin ^g   Warman, Matthew L ^g   De Vernejoul, Marie Christine ^d   Bollerslev, Jens ^h   Van Hul, Wim ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ESBJERG HOSPITAL   (Denmark)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d INSERM   (France)

^e SPIRITO SANTO HOSPITAL   (Italy)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h OSLO UNIVERSITY HOSPITAL   (Norway)

ⁱ NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALBERS SCHOENBERG DISEASE; AMINO TERMINAL SEQUENCE; ARTICLE; BONE DENSITY; BONE MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL BONE; FAMILY; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HUMAN; HYPEROSTOSIS; MALE; MISSENSE MUTATION; OSTEOSCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE ALIGNMENT;

VERTEBRATA;

EID: 0037373341     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/368277     Document Type: Article

References (26)

1. Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C, Wuyts W, Van Den Ende J, Willems P, Peas-Alvers AF, Hill S, Bueno M, Ramos FJ, Tacconi P, Dikkers FG, Stratakis C, Lindpainter K, Vickery B, Foernzler D, Van Hul W (2001) Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 10:537-543
2. Balemans W, Patel N, Ebeling M, Van Hul E, Wuyts W, Lacza C, Dioszegi M, Dikkers FG, Hildering P, Willems PJ, Verheij JB, Lindpaintner K, Vickery B, Foernzler D, Van Hul W (2002) Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet 39:91-97
3. Beals RK (1976) Endosteal hyperostosis. J Bone Joint Surg Am 58:1172-1173
4. Beals RK, McLoughlin SW, Teed RL, McDonald C (2001) Dominant endosteal hyperostosis: skeletal characteristics and review of the literature. J Bone Joint Surg Am 83A:1643-1649
5. Bollerslev J, Andersen PE Jr (1988) Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis. Bone 9:7-13
6. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513-1521
7. Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, Skonier JE, Zhao L, Sabo PJ, Fu Y-H, Alisch RS, Gillett L, Colbert T, Tacconi P, Galas D, Hamersma H, Beighton P, Mulligan JT (2001) Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 68:577-589
8. Cleiren E, Benichou O, Van Hul E, Gram J, Bollerslev J, Singer FR, Beaverson K, Aledo A, Whyte MP, Yoneyama T, de Vernejoul MC, Van Hul W (2001) Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the CLCN7 chloride channel gene. Hum Mol Genet 10:2861-2867
9. Frattini A, Orchard PJ, Sobacchi C, Giliani S, Abinum M, Mattson JP, Keeling DJ, Andersson AK, Wallbrandt P, Zecca L, Notarangelo LD, Vezzoni P, Villa A (2000) Defects in the TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet 25:343-346
10. Gong Y, Slee RB, Fukai N, Rawadi G, Roman R, Regniato AM, Cundy T, et al (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513-523
11. Gong Y, Vikkula M, Boon L, Liu J, Beighton P, Ramesar R, Peltonen L, Somer H, Hirose T, Dallapiccola B, De Paepe, A, Swoboda W, Zabel B, Superti-Furga A, Steinmann B, Brunner HG, Jans A, Boles RG, Adkins W, van den Boogaard M-J, Olsen BR, Warman ML (1996) Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13. Am J Hum Genet 59:146-151
12. Janssens K, Gershoni-Baruch R, Guanabens N, Migone N, Ralston S, Bonduelle M, Lissens W, Van Maldergem L, Vanhoenacker F, Verbruggen L, Van Hul W (2000) Mutations in the gene encoding the latency-associated peptide of TGF-β 1 cause Camurati-Engelmann disease. Nat Genet 26:273-275
13. Jeon H, Meng W, Takagi J, Eck MJ, Springer TA, Blacklow SC (2001) Implications for familial hypercholesterolemia from the structure of the LDL receptor YWTD-EGF domain pair. Nat Struct Biol 8:499-504
14. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass DA, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L (2002) Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157:303-314
15. Kinoshita A, Saito T, Tomita H, Makita Y, Yoshida K, Ghadami M, Yamada K, Kondo S, Ikegawa S, Nishimura G, Fukushima Y, Nakagomi T, Saito H, Sugimoto T, Kamegaya M, Hisa K, Murray JC, Taniguchi N, Niikawa N, Yoshiura K (2000) Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease. Nat Genet 26:19-20
16. Kornak U, Kasper D, Bosl MR, Kaiser E, Schweizer M, Schulz A, Friedrich W, Delling G, Jentsch TJ (2001) Loss of the CLC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104:205-215
17. Kornak U, Schulz A, Friedrich W, Uhlhass S, Kremens B, Voit T, Hasan C, Bode U, Jentsch TJ, Kubisch C (2000) Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. Hum Mol Genet 9:2059-2063
18. Little RD, Carulli JP, Del M, Dupuis J, Osborne M, Folz C, Manning SP, et al (2002) A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70:11-19
19. Nürnberg P, Thiele H, Chandler D, Hohne W, Cunningham ML, Ritter H, Leschik G, Uhlmann K, Mischung C, Harrop K, Goldblatt J, Borochowitz ZU, Kotzot D, Westermann F, Mundlos S, Braun HS, Laing N, Tinschert S (2001) Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia. Nat Genet 28:37-41
20. Okubo M, Horinishi A, Kim DH, Yamamoto TT, Murase T (2002) Seven novel sequence variants in the human low density lipoprotein receptor related protein 5 (LRP5) gene. Hum Mutat 19:186
21. Reichenberger E, Tiziani V, Watanabe S, Park L, Ueki Y, Santanna C, Baur ST, Shiang R, Grange DK, Beighton P, Gardner J, Hamersma H, Sellars S, Ramesar R, Lidral AC, Sommer A, Raposo do Amaral CM, Gorlin RJ, Mulliken JB, Olsen BR (2001) Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am J Hum Genet 68:1321-1326
22. Renton T, Odell E, Drage NA (2002) Differential diagnosis and treatment of autosomal dominant osteosclerosis of the mandible. Br J Oral Maxillofac Surg 40:55-59
23. Scopelliti D, Orsinin R, Ventucci D, Carratelli D (1999) Malattia di Van Buchem. Minerva Stomatol 48:227-234
24. Van Gaal L, De Leeuw I, Abs R (1978) Familiale benigne osteopetrose. Tijdschrift voor Geneeskunde 24:1597-1603
25. Van Hul E, Gram J, Bollerslev J, Van Wesenbeeck L, Mathysen D, Andersen PE, Vanhoenacker F, Van Hul W (2002) Localization of the gene causing autosomal dominant osteopetrosis type I to chromosome 11q12-13. J Bone Miner Res 17:1111-1117
26. Whyte MP (1999) Sclerosing bone disorders. In: Favus M-J (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 4th ed. Lippincott Williams and Wilkins, Philadelphia, pp 367-383